Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Beyond Air, Inc.XAIR · Entity 8379 | Director · CEO and Chairman of the Board | November 04, 2025 | November 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Beyond Air, Inc.
Report date November 04, 2025 · Filed November 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-04 · Disposition to issuer · Disposed 47,500 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 47,500 |
Reported balance
After 2025-11-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-04 · Grant · Acquired 47,500 · Balance 47,500 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-11-04 · Disposition to issuer · Disposed 40,000 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 40,000 |
Reported balance
After 2025-11-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-04 · Grant · Acquired 40,000 · Balance 40,000 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-11-04 · Disposition to issuer · Disposed 14,000 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 14,000 |
Reported balance
After 2025-11-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-11-04 · Grant · Acquired 14,000 · Balance 14,000 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-11-04 · Disposition to issuer · Disposed 10,000 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 10,000 |
Reported balance
After 2025-11-04 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-11-04 · Grant · Acquired 10,000 · Balance 10,000 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-11-04 · Disposition to issuer · Disposed 3,500 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 3,500 |
Reported balance
After 2025-11-04 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2025-11-04 · Grant · Acquired 3,500 · Balance 3,500 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2025-11-04 · Disposition to issuer · Disposed 12,500 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 12,500 |
Reported balance
After 2025-11-04 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2025-11-04 · Grant · Acquired 12,500 · Balance 12,500 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-11-04 · Disposition to issuer · Disposed 20,000 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 20,000 |
Reported balance
After 2025-11-04 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-11-04 · Grant · Acquired 20,000 · Balance 20,000 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.89 | Direct | 0 |
Reported balance
After 2025-11-04 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-11-04 · Disposition to issuer · Disposed 47,500 · Balance 0 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 | Direct | 47,500 |
Reported balance
After 2025-11-04 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-11-04 · Grant · Acquired 47,500 · Balance 47,500 F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged. F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged.
F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2022 Filed Mar 7, 2022 08:33 UTC | Beyond Air, Inc. XAIR · Entity 8379 | GrantStock Option (right to buy) · Derivative | 280,000 | $0.00 Strike: $6.87 | $0.00 |
DisclosureSEC source: 0001493152-22-006148 · ownership.xml · derivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2032-03-02 F2 · derivative.exercise_date: The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2022, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 08:33 UTC | Beyond Air, Inc. XAIR · Entity 8379 | GrantCommon Stock | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-006148 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373,445 F1 · shares: Represents grant of time-vested restricted stock units ("RSUs") under the Beyond Air, Inc. Fourth Amended and Restated 2013 Equity Incentive Plan. The award will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2022, with the remainder vesting in equal annual installments on December 15th of each of the four ensuing years thereafter until vested in full. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 08:30 UTC | Beyond Air, Inc. XAIR · Entity 8379 | Exercise / conversionWarrants (right to buy) · Derivative | 83,334 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001493152-22-001198 · ownership.xml · derivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,334 shares Expires 2022-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 12, 2022, the reporting person exercised a warrant to purchase 83,334 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. for $3.66 a share. The reported transactions were exempt from Section 16(b) in accordance with Rule 16b-3 and Rule 16b-6. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 08:30 UTC | Beyond Air, Inc. XAIR · Entity 8379 | Exercise / conversionCommon Stock | 83,334 | $3.66 | $305,002.44 |
DisclosureSEC source: 0001493152-22-001198 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 12, 2022, the reporting person exercised a warrant to purchase 83,334 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. for $3.66 a share. The reported transactions were exempt from Section 16(b) in accordance with Rule 16b-3 and Rule 16b-6. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | SaleCommon Stock | 21,376 | $9.53 | $203,756.03 |
DisclosureSEC source: 0001493152-22-000113 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,111 F1 · kind: The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. (the "Company") sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units. The reporting person's sale of the Company's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 21,376 shares, with the reporting person's purchase of 25,000 shares of the Company's common stock at a weighted average price of $7.85 per share on August 13, 2021. The reporting person has paid to the Company, and the Company has received, $37,675, representing the full amount of the profit realized in connection with the short-swing transaction. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.70, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 40,000 | $8.53 | $341,200.00 |
DisclosureSEC source: 0001493152-21-031287 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,171,487 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.41 to $8.81, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 16:10 UTC | Beyond Air, Inc. XAIR · Entity 8379 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-024932 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,487 F1 · shares: Represents grant of time-vested restricted stock units ("RSUs") under the Beyond Air, Inc. Third Amended and Restated 2013 Equity Incentive Plan. The award will vest as to 20% of the shares of common stock underlying the RSUs on December 23, 2021, with the remainder vesting in equal annual installments on December 23rd (or the first business day thereafter if December 23rd falls on a weekend or holiday) of each of the four ensuing years thereafter until vested in full. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 25,000 | $7.85 | $196,250.00 |
DisclosureSEC source: 0001493152-21-020441 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,487 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77 to $7.90, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 16:49 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 25,000 | $5.36 | $134,000.00 |
DisclosureSEC source: 0001493152-21-014875 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006,487 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.299 to $5.374, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 20:00 UTC | Beyond Air, Inc. XAIR · Entity 8379 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001493152-21-005626 · ownership.xml · derivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-03-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2021, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:25 UTC | Beyond Air, Inc. XAIR · Entity 8379 | OtherTranche B Warrant (right to buy) · Derivative | 117,112 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001493152-21-003654 · ownership.xml · derivative · entry 3 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,112 shares Expires 2021-02-16 Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:25 UTC | Beyond Air, Inc. XAIR · Entity 8379 | SaleCommon Stock | 70,388 | $7.07 | $497,734.66 |
DisclosureSEC source: 0001493152-21-003654 · ownership.xml · nonDerivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981,487 F1 · kind: On February 10, 2021, the reporting person exercised a warrant to purchase 117,112 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the "Company") for $4.25 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 70,388 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 46,724 shares of common stock of the Company. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:25 UTC | Beyond Air, Inc. XAIR · Entity 8379 | OtherCommon Stock | 117,112 | $4.25 | $497,726.00 |
DisclosureSEC source: 0001493152-21-003654 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,875 Read SEC document |
| February 10, 2021 Filed Mar 3, 2021 16:25 UTC Amendment | Beyond Air, Inc. XAIR · Entity 8379 | Exercise / conversionTranche B Warrant (right to buy) · Derivative | 117,112 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001493152-21-005282 · ownership.xml · derivative · entry 3 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,112 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2021 Filed Mar 3, 2021 16:25 UTC Amendment | Beyond Air, Inc. XAIR · Entity 8379 | Tax withholdingCommon Stock | 70,388 | $7.07 | $497,734.66 |
DisclosureSEC source: 0001493152-21-005282 · ownership.xml · nonDerivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981,487 F1 · kind: On February 10, 2021, the reporting person exercised a warrant to purchase 117,112 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the "Company") for $4.25 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 70,388 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 46,724 shares of common stock of the Company. Read SEC document |
| February 10, 2021 Filed Mar 3, 2021 16:25 UTC Amendment | Beyond Air, Inc. XAIR · Entity 8379 | Exercise / conversionCommon Stock | 117,112 | $4.25 | $497,726.00 |
DisclosureSEC source: 0001493152-21-005282 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 17:00 UTC | Beyond Air, Inc. XAIR · Entity 8379 | GrantCommon Stock | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-000332 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934,763 Read SEC document |
| December 31, 2020 Filed Dec 31, 2020 17:29 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 38,500 | $5.28 | $203,280.00 |
DisclosureSEC source: 0001493152-20-024709 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 929.263 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 17:00 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 20,000 | $5.55 | $110,940.00 |
DisclosureSEC source: 0001493152-20-016216 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 890,763 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transaction in prices ranging from 5.45 to 5.54. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 08:30 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 35,000 | $7.45 | $260,750.00 |
DisclosureSEC source: 0001493152-20-012024 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870,763 Read SEC document |
| December 30, 2019 Filed Dec 31, 2019 16:00 UTC | Beyond Air, Inc. XAIR · Entity 8379 | SaleCommon Stock | 5,992 | $4.43 | $26,555.35 |
DisclosureSEC source: 0001493152-19-019925 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815,763 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $4.38 to $4.47, inclusive. The Reporting Person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 190,437 | $3.66 | $696,999.42 |
DisclosureSEC source: 0001493152-19-019291 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821,755 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 18:01 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 10,000 | $4.09 | $40,873.00 |
DisclosureSEC source: 0001493152-19-017869 · ownership.xml · nonDerivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,318 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.0523 to $4.15, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 18:01 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 10,000 | $4.04 | $40,440.00 |
DisclosureSEC source: 0001493152-19-017869 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,318 Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 12,000 | $4.09 | $49,080.00 |
DisclosureSEC source: 0001493152-19-017472 · ownership.xml · nonDerivative · entry 4 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,318 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.051 to $4.14, inclusive. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 8,000 | $4.07 | $32,560.00 |
DisclosureSEC source: 0001493152-19-017472 · ownership.xml · nonDerivative · entry 3 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599,318 Read SEC document |
| November 11, 2019 Filed Nov 14, 2019 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 10,000 | $4.19 | $41,900.00 |
DisclosureSEC source: 0001493152-19-017472 · ownership.xml · nonDerivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,318 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.3452, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 03, 2019 Filed Nov 14, 2019 16:15 UTC | Beyond Air, Inc. XAIR · Entity 8379 | PurchaseCommon Stock | 58,253 | $5.15 | $300,002.95 |
DisclosureSEC source: 0001493152-19-017472 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,318 F1 · price: Closing price of common stock on May 31, 2019. Read SEC document |
| January 01, 2019 Filed Feb 25, 2019 16:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-002501 · ownership.xml · nonDerivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,286 F1 · shares: Represents restricted stock award that vest in five equal annual installments commencing on the date of grant. Read SEC document |
| December 31, 2018 Filed Feb 25, 2019 16:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | GrantCommon Stock | 88,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-002501 · ownership.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,286 F1 · shares: Represents restricted stock award that vest in five equal annual installments commencing on the date of grant. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 17:27 UTC | Beyond Air, Inc. AITB · Entity 8379 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001493152-18-012106 · ownership.xml · derivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-08-12 F1 · derivative.exercise_date: The options will vest as to 25% of the shares on the date of grant, 25% on December 31, 2018 and on December 31 of each of the two ensuing years thereafter until vested in full. Read SEC document |
| February 16, 2018 Filed Apr 26, 2018 17:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | Exercise / conversionTranche A Warrant (right to buy) · Derivative | 117,112 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001178913-18-001294 · zk1821545.xml · derivative · entry 4 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 117,112 shares Expires 2018-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Apr 26, 2018 17:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | PurchaseTranche A Warrant (right to buy) · Derivative | 117,112 | $0.01 Strike: $4.25 | $1,171.12 |
DisclosureSEC source: 0001178913-18-001294 · zk1821545.xml · derivative · entry 3 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,112 Underlying: Common stock · 117,112 shares Expires 2021-02-15 Read SEC document |
| February 16, 2018 Filed Apr 26, 2018 17:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | PurchaseTranche A Warrant (right to buy) · Derivative | 117,112 | $0.01 Strike: $4.25 | $1,171.12 |
DisclosureSEC source: 0001178913-18-001294 · zk1821545.xml · derivative · entry 2 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,112 Underlying: Common stock · 117,112 shares Expires 2018-02-19 Read SEC document |
| February 16, 2018 Filed Apr 26, 2018 17:30 UTC | Beyond Air, Inc. AITB · Entity 8379 | Exercise / conversionCommon Stock | 117,112 | $4.25 | $497,726.00 |
DisclosureSEC source: 0001178913-18-001294 · zk1821545.xml · nonDerivative · entry 1 Lisi Steven A. · CIK 0001702628 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.